Related Experiment Video
Updated: Mar 7, 2026
Cholesterol Efflux Assay
Published on: March 6, 2012
Serum cholesterol acceptor capacity in intrauterine growth restricted fetuses
Insights
Intrauterine growth restriction (IUGR) is linked to reduced cholesterol efflux, a key factor in cardiovascular disease development. This impaired cholesterol transport in IUGR may explain the increased vascular risk later in life.
Area of Science:
- Cardiovascular Science
- Metabolic Research
- Developmental Biology
Background:
- Intrauterine growth restriction (IUGR) is a known risk factor for adult cardiovascular diseases.
- Disturbed cholesterol homeostasis, particularly impaired cholesterol efflux, is implicated in atherosclerosis.
- The precise mechanisms linking IUGR to later vascular risk are not fully understood.
Purpose of the Study:
- To investigate whether serum from IUGR pregnancies impairs cholesterol efflux.
- To test the hypothesis that altered cholesterol acceptors in IUGR serum interfere with cellular cholesterol transport.
Main Methods:
- Utilized RAW264.7 macrophage cells to assess cholesterol efflux.
- Measured [3H]-cholesterol efflux in response to umbilical cord serum from IUGR (n=20) and control (n=20) groups.
Main Results:
- Cholesterol efflux was significantly lower in the IUGR group (6.3% ± 0.79) compared to controls (7.7% ± 0.98; P<0.0001).
- Reduced efflux in IUGR serum correlated strongly with HDL and apoE concentrations, and moderately with apoA1 levels.
Conclusions:
- Diminished cholesterol efflux capacity in IUGR may contribute to the elevated risk of cardiovascular disease observed later in life.
- These findings highlight a potential mechanism linking fetal growth restriction to vascular pathology.
Aim:
Intrauterine growth restriction (IUGR) is an independent risk factor for the development of cardiovascular diseases later in life. The mechanisms whereby slowed intrauterine growth confers vascular risk are not clearly established. In general, a disturbed cholesterol efflux has been linked to atherosclerosis. The capacity of serum to accept cholesterol has been repeatedly evaluated in clinical studies by the use of macrophage-based cholesterol efflux assays and, if disturbed, precedes atherosclerotic diseases years before the clinical diagnosis. We now hypothesized that circulating cholesterol acceptors in IUGR sera specifically interfere with cholesterol transport mechanisms leading to diminished cholesterol efflux.
Methods:
RAW264.7 cells were used to determine efflux of [3H]-cholesterol in response to [umbilical cord serum (IUGR), n=20; controls (CTRL), n=20].
Results:
Cholesterol efflux was lower in IUGR as compared to controls [controls: mean 7.7% fractional [3H]-cholesterol efflux, standard deviation (SD)=0.98; IUGR: mean 6.3%, SD=0.79; P<0.0001]. Values strongly correlated to HDL (ρ=0.655, P<0.0001) and apoE (ρ=0.510, P=0.0008), and mildly to apoA1 (ρ=0.3926, P=0.0122) concentrations.
Conclusions:
Reduced cholesterol efflux in IUGR could account for the enhanced risk of developing cardiovascular diseases later in life.
